Zonisamide( CAS 68291-97-4) is a sulfonamide anticonvulsant approved for use as an adjunctive therapy in adults with partial-onset seizures; infantile spasm, mixed seizure types of Lennox–Gastaut syndrome, myoclonic, and generalized tonic clonic seizure. <span style="font-size:12px;"><span style="font-family: -apple-system, system-ui, "Segoe UI", Roboto, Oxygen, Oxygen-Sans, Ubuntu, Cantarell, "Fira Sans", "Droid Sans", "Helvetica Neue", "Source Sans Pro", sans-serif; font-variant-ligatures: normal; orphans: 2; widows: 2;">Zonisamide appears to block sodium </span><span style="font-family: -apple-system, system-ui, "Segoe UI", Roboto, Oxygen, Oxygen-Sans, Ubuntu, Cantarell, "Fira Sans", "Droid Sans", "Helvetica Neue", "Source Sans Pro", sans-serif; font-variant-ligatures: normal; orphans: 2; widows: 2;">and </span><span style="font-family: -apple-system, system-ui, "Segoe UI", Roboto, Oxygen, Oxygen-Sans, Ubuntu, Cantarell, "Fira Sans", "Droid Sans", "Helvetica Neue", "Source Sans Pro", sans-serif; font-variant-ligatures: normal; orphans: 2; widows: 2;">calcium channels, thereby stabilizing neuronal membranes and suppressing neuronal hyper-synchronization. Although zonisamide shows affinity for the gamma-aminobutyric acid (GABA)/benzodiazepine </span><span style="font-family: -apple-system, system-ui, "Segoe UI", Roboto, Oxygen, Oxygen-Sans, Ubuntu, Cantarell, "Fira Sans", "Droid Sans", "Helvetica Neue", "Source Sans Pro", sans-serif; font-variant-ligatures: normal; orphans: 2; widows: 2;">receptor ionophore complex, it does not potentiate the synaptic activity of GABA.</span><span style="font-family: -apple-system, system-ui, "Segoe UI", Roboto, Oxygen, Oxygen-Sans, Ubuntu, Cantarell, "Fira Sans", "Droid Sans", "Helvetica Neue", "Source Sans Pro", sans-serif; font-variant-ligatures: normal; orphans: 2; widows: 2;"> In addition, this agent also facilitates both dopaminergic and serotonergic neurotransmission.</span></span>